history of glp 1 agonists glucagon-like peptide-1 receptor GLP-1 Receptor Agonist Market Size

CagriSema combines semaglutide with cagrilintide, an amylin analogue

The potential actions of GLP-1 medicines in modulating astrocyte-mediated neuroinflammation have not been extensively explored

Ultimately, careful monitoring, patient education, and individualized treatment plans are key

Weight Management Program

By addressing multiple pathophysiological pathways, including insulin resistance, inflammation, and oxidative stress, Tirzepatide presents a unique opportunity to redefine treatment paradigms beyond glycemic management

As noted by Manasyan et al., while these agents reduce insulin requirements and maintain adequate glucose control with fewer hypoglycemic events, they may simultaneously impede adequate nutrition as a result of delayed gastric emptying and present a risk of aspiration